Intellipharmaceutics Settles Patent Litigation With AstraZeneca Concerning Generic Seroquel XR(R) – NBCNews.com
TORONTO, July 31, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted ...
Subscribe to LegalLaw247.Com Newsletter